Researchers have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets multiple molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors use to survive.
source https://www.sciencedaily.com/releases/2024/06/240619182323.htm
Sulfolobus islandicus: Expanding the genetic toolkit for drug delivery and
biotechnology applications
-
Sulfolobus islandicus, an archaeal model organism, offers unique advantages
for metabolic engineering and synthetic biology applications owing to its
abili...
3 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment